Furthermore, USP15 mutations can increase the sensitivity of cancer cells to poly ADP ribose polymerase (PARP) inhibitors that selectively kill breast and ovarian cancer cells with defects in homologous recombination. Here, USP15 is linked to ovarian cancer.